Detalhe da pesquisa
1.
T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Am J Hematol
; 99(3): 494-496, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240336
2.
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.
Haematologica
; 108(11): 3025-3032, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102592
3.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw
; 21(11): 1118-1131, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935098
4.
Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia.
Am J Hematol
; 98(7): E172-E174, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078687
5.
Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation.
J Natl Compr Canc Netw
; 20(6): 618-621, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325867
6.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw
; 19(11): 1218-1230, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781267
7.
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
Blood
; 131(16): 1820-1832, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358183
8.
Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments.
Br J Haematol
; 185(5): 852-864, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924136
9.
Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients.
Br J Haematol
; 187(3): 307-318, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243771
10.
Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy.
Clin Lymphoma Myeloma Leuk
; 24(2): 94-104.e6, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000981
11.
Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era.
Leuk Lymphoma
; 64(2): 356-363, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408967
12.
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Cancer Med
; 12(3): 2624-2636, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812123
13.
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
Blood Adv
; 7(21): 6630-6638, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595053
14.
Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy.
Adv Radiat Oncol
; 7(6): 101035, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420188
15.
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma.
Blood Adv
; 6(2): 473-485, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495306
16.
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
Clin Cancer Res
; 28(15): 3242-3247, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608822
17.
Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk.
J Transl Genet Genom
; 5: 189-199, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34368645
18.
How I Evaluate a High Anion Gap Metabolic Acidosis.
Clin J Am Soc Nephrol
; 19(4): 525-527, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976122
19.
Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.
Front Oncol
; 8: 139, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761078
20.
Blistering Lesions Associated With Loncastuximab Tesirine.
JAMA Dermatol
; 158(7): 831-832, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583892